Fusion Protein Therapy Market Insights, Global Outlook and Forecast 2022-2028
Fusion Protein Therapy Market Insights, Global Outlook and Forecast 2022-2028
Fusion Protein Therapy Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Fusion proteins or chimeric (kī-ˈmir-ik) proteins (literally, made of parts from different sources) are proteins created through the joining of two or more genes that originally coded for separate proteins.
The latest research study released by Market IntelliX evaluates market size and forecasts of Fusion Protein Therapy in Global, including the following market information:
Global Fusion Protein Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fusion Protein Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunoglobulin (Ig) Fusion Protein Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fusion Protein Therapy include Roche, Abnova, Novus, Origene, Chimerigen, Peprotech, Prospec, Aboslute Antibody and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Fusion Protein Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Fusion Protein Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fusion Protein Therapy Market Segment Percentages, by Type, 2021 (%)
Immunoglobulin (Ig) Fusion Protein
Parathyroid Hormone (PTH) Fusion Protein
Cytokines Recombinant Fusion Protein
Others
Global Fusion Protein Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fusion Protein Therapy Market Segment Percentages, by Application, 2021 (%)
Chimeric Protein Drugs
Biological Technology
Others
Global Fusion Protein Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fusion Protein Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fusion Protein Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fusion Protein Therapy revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Roche
Abnova
Novus
Origene
Chimerigen
Peprotech
Prospec
Aboslute Antibody
Amgen
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Fusion Protein Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fusion Protein Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fusion Protein Therapy Overall Market Size
2.1 Global Fusion Protein Therapy Market Size: 2021 VS 2028
2.2 Global Fusion Protein Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fusion Protein Therapy Players in Global Market
3.2 Top Global Fusion Protein Therapy Companies Ranked by Revenue
3.3 Global Fusion Protein Therapy Revenue by Companies
3.4 Top 3 and Top 5 Fusion Protein Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Fusion Protein Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fusion Protein Therapy Players in Global Market
3.6.1 List of Global Tier 1 Fusion Protein Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Fusion Protein Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Fusion Protein Therapy Market Size Markets, 2021 & 2028
4.1.2 Immunoglobulin (Ig) Fusion Protein
4.1.3 Parathyroid Hormone (PTH) Fusion Protein
4.1.4 Cytokines Recombinant Fusion Protein
4.1.5 Others
4.2 By Type - Global Fusion Protein Therapy Revenue & Forecasts
4.2.1 By Type - Global Fusion Protein Therapy Revenue, 2017-2022
4.2.2 By Type - Global Fusion Protein Therapy Revenue, 2023-2028
4.2.3 By Type - Global Fusion Protein Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fusion Protein Therapy Market Size, 2021 & 2028
5.1.2 Chimeric Protein Drugs
5.1.3 Biological Technology
5.1.4 Others
5.2 By Application - Global Fusion Protein Therapy Revenue & Forecasts
5.2.1 By Application - Global Fusion Protein Therapy Revenue, 2017-2022
5.2.2 By Application - Global Fusion Protein Therapy Revenue, 2023-2028
5.2.3 By Application - Global Fusion Protein Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Fusion Protein Therapy Market Size, 2021 & 2028
6.2 By Region - Global Fusion Protein Therapy Revenue & Forecasts
6.2.1 By Region - Global Fusion Protein Therapy Revenue, 2017-2022
6.2.2 By Region - Global Fusion Protein Therapy Revenue, 2023-2028
6.2.3 By Region - Global Fusion Protein Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Fusion Protein Therapy Revenue, 2017-2028
6.3.2 US Fusion Protein Therapy Market Size, 2017-2028
6.3.3 Canada Fusion Protein Therapy Market Size, 2017-2028
6.3.4 Mexico Fusion Protein Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Fusion Protein Therapy Revenue, 2017-2028
6.4.2 Germany Fusion Protein Therapy Market Size, 2017-2028
6.4.3 France Fusion Protein Therapy Market Size, 2017-2028
6.4.4 U.K. Fusion Protein Therapy Market Size, 2017-2028
6.4.5 Italy Fusion Protein Therapy Market Size, 2017-2028
6.4.6 Russia Fusion Protein Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Fusion Protein Therapy Market Size, 2017-2028
6.4.8 Benelux Fusion Protein Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Fusion Protein Therapy Revenue, 2017-2028
6.5.2 China Fusion Protein Therapy Market Size, 2017-2028
6.5.3 Japan Fusion Protein Therapy Market Size, 2017-2028
6.5.4 South Korea Fusion Protein Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Fusion Protein Therapy Market Size, 2017-2028
6.5.6 India Fusion Protein Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Fusion Protein Therapy Revenue, 2017-2028
6.6.2 Brazil Fusion Protein Therapy Market Size, 2017-2028
6.6.3 Argentina Fusion Protein Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fusion Protein Therapy Revenue, 2017-2028
6.7.2 Turkey Fusion Protein Therapy Market Size, 2017-2028
6.7.3 Israel Fusion Protein Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Fusion Protein Therapy Market Size, 2017-2028
6.7.5 UAE Fusion Protein Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Fusion Protein Therapy Major Product Offerings
7.1.4 Roche Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Abnova
7.2.1 Abnova Corporate Summary
7.2.2 Abnova Business Overview
7.2.3 Abnova Fusion Protein Therapy Major Product Offerings
7.2.4 Abnova Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.2.5 Abnova Key News
7.3 Novus
7.3.1 Novus Corporate Summary
7.3.2 Novus Business Overview
7.3.3 Novus Fusion Protein Therapy Major Product Offerings
7.3.4 Novus Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.3.5 Novus Key News
7.4 Origene
7.4.1 Origene Corporate Summary
7.4.2 Origene Business Overview
7.4.3 Origene Fusion Protein Therapy Major Product Offerings
7.4.4 Origene Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.4.5 Origene Key News
7.5 Chimerigen
7.5.1 Chimerigen Corporate Summary
7.5.2 Chimerigen Business Overview
7.5.3 Chimerigen Fusion Protein Therapy Major Product Offerings
7.5.4 Chimerigen Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.5.5 Chimerigen Key News
7.6 Peprotech
7.6.1 Peprotech Corporate Summary
7.6.2 Peprotech Business Overview
7.6.3 Peprotech Fusion Protein Therapy Major Product Offerings
7.6.4 Peprotech Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.6.5 Peprotech Key News
7.7 Prospec
7.7.1 Prospec Corporate Summary
7.7.2 Prospec Business Overview
7.7.3 Prospec Fusion Protein Therapy Major Product Offerings
7.7.4 Prospec Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.7.5 Prospec Key News
7.8 Aboslute Antibody
7.8.1 Aboslute Antibody Corporate Summary
7.8.2 Aboslute Antibody Business Overview
7.8.3 Aboslute Antibody Fusion Protein Therapy Major Product Offerings
7.8.4 Aboslute Antibody Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.8.5 Aboslute Antibody Key News
7.9 Amgen
7.9.1 Amgen Corporate Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Fusion Protein Therapy Major Product Offerings
7.9.4 Amgen Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.9.5 Amgen Key News
7.10 Abbvie
7.10.1 Abbvie Corporate Summary
7.10.2 Abbvie Business Overview
7.10.3 Abbvie Fusion Protein Therapy Major Product Offerings
7.10.4 Abbvie Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.10.5 Abbvie Key News
7.11 J & J
7.11.1 J & J Corporate Summary
7.11.2 J & J Business Overview
7.11.3 J & J Fusion Protein Therapy Major Product Offerings
7.11.4 J & J Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.11.5 J & J Key News
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Corporate Summary
7.12.2 Bristol-Myers Squibb Business Overview
7.12.3 Bristol-Myers Squibb Fusion Protein Therapy Major Product Offerings
7.12.4 Bristol-Myers Squibb Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.12.5 Bristol-Myers Squibb Key News
7.13 Novartis
7.13.1 Novartis Corporate Summary
7.13.2 Novartis Business Overview
7.13.3 Novartis Fusion Protein Therapy Major Product Offerings
7.13.4 Novartis Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.13.5 Novartis Key News
7.14 Merck
7.14.1 Merck Corporate Summary
7.14.2 Merck Business Overview
7.14.3 Merck Fusion Protein Therapy Major Product Offerings
7.14.4 Merck Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.14.5 Merck Key News
7.15 Alexion Pharmaceuticals
7.15.1 Alexion Pharmaceuticals Corporate Summary
7.15.2 Alexion Pharmaceuticals Business Overview
7.15.3 Alexion Pharmaceuticals Fusion Protein Therapy Major Product Offerings
7.15.4 Alexion Pharmaceuticals Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.15.5 Alexion Pharmaceuticals Key News
7.16 Takeda
7.16.1 Takeda Corporate Summary
7.16.2 Takeda Business Overview
7.16.3 Takeda Fusion Protein Therapy Major Product Offerings
7.16.4 Takeda Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.16.5 Takeda Key News
7.17 Biogen
7.17.1 Biogen Corporate Summary
7.17.2 Biogen Business Overview
7.17.3 Biogen Fusion Protein Therapy Major Product Offerings
7.17.4 Biogen Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.17.5 Biogen Key News
7.18 UCB
7.18.1 UCB Corporate Summary
7.18.2 UCB Business Overview
7.18.3 UCB Fusion Protein Therapy Major Product Offerings
7.18.4 UCB Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.18.5 UCB Key News
7.19 Eli Lilly and Company
7.19.1 Eli Lilly and Company Corporate Summary
7.19.2 Eli Lilly and Company Business Overview
7.19.3 Eli Lilly and Company Fusion Protein Therapy Major Product Offerings
7.19.4 Eli Lilly and Company Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.19.5 Eli Lilly and Company Key News
7.20 AstraZeneca
7.20.1 AstraZeneca Corporate Summary
7.20.2 AstraZeneca Business Overview
7.20.3 AstraZeneca Fusion Protein Therapy Major Product Offerings
7.20.4 AstraZeneca Fusion Protein Therapy Revenue in Global Market (2017-2022)
7.20.5 AstraZeneca Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Fusion Protein Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|